Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002207929 | SCV002378932 | benign | not provided | 2023-09-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003161434 | SCV003877849 | likely benign | Inborn genetic diseases | 2023-02-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV002207929 | SCV004140533 | benign | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | KCNC3: BS1, BS2 |
Revvity Omics, |
RCV003485761 | SCV004235860 | uncertain significance | Spinocerebellar ataxia type 13 | 2023-10-27 | criteria provided, single submitter | clinical testing |